| 1 |
31421661 | The utility of surrogate markers in predicting HLA alleles associated with adverse drug reactions in Vietnamese. | 2022 Jun |
1 |
| 2 |
34350628 | Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine. | 2022 Feb |
1 |
| 3 |
35070271 | Reducing severe cutaneous adverse and type B adverse drug reactions using pre-stored human leukocyte antigen genotypes. | 2022 Jan |
1 |
| 4 |
35187767 | Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population. | 2022 May |
2 |
| 5 |
35496269 | Single Nucleotide Variants as Proxies for HLA-A*31:01 in Native American Populations. | 2022 |
1 |
| 6 |
35526384 | Carbamazepine-modified HLA-A*24:02-bound peptidome: Implication of CORO1A in skin rash. | 2022 Aug |
6 |
| 7 |
35599240 | Associations of HLA genetic variants with carbamazepine-induced cutaneous adverse drug reactions: An updated meta-analysis. | 2022 May 22 |
3 |
| 8 |
32909461 | Human Leukocyte Antigen Gene Testing and Carbamazepine-Induced Toxic Epidermal Necrolysis: A Study of Pediatric Practice. | 2021 Jan-Feb |
1 |
| 9 |
33147643 | Review and Consensus on Pharmacogenomic Testing in Psychiatry. | 2021 Jan |
1 |
| 10 |
33728835 | Severe cutaneous adverse drug reactions: diagnostic approach and genetic study in a Brazilian case series. | 2021 Mar 16 |
1 |
| 11 |
33910375 | HLA-A*24:07 as a potential biomarker for carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Filipino patients. | 2021 Jun |
2 |
| 12 |
34122097 | HLA Risk Alleles in Aromatic Antiepileptic Drug-Induced Maculopapular Exanthema. | 2021 |
1 |
| 13 |
34381365 | Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B*15:02 and HLA-A*31:01 Across Diverse Ancestral Backgrounds. | 2021 |
1 |
| 14 |
32180714 | Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics. | 2020 |
3 |
| 15 |
32714190 | Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions. | 2020 |
1 |
| 16 |
30826555 | Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population. | 2019 Mar |
1 |
| 17 |
31066027 | Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions. | 2019 Nov |
2 |
| 18 |
31618895 | The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity. | 2019 Oct 15 |
4 |
| 19 |
32055583 | Antiepileptic drug-induced severe cutaneous adverse reactions and HLA alleles: A report of five cases with lymphocyte activation test. | 2019 Jun |
1 |
| 20 |
29288229 | Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients. | 2018 Jan 23 |
1 |
| 21 |
29350020 | Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population. | 2018 Jan |
2 |
| 22 |
29392710 | Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update. | 2018 Apr |
1 |
| 23 |
29610831 | Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population. | 2018 Jul 1 |
5 |
| 24 |
29925289 | Single-tube multiplex real-time PCR assay for rapid and reliable detection of HLA-A*31:01 allele. | 2018 Jul 1 |
2 |
| 25 |
30471757 | Major Histocompatibility Complex and Psoriasis. | 2018 Dec |
1 |
| 26 |
27888155 | Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population. | 2017 Jan |
3 |
| 27 |
28203102 | The HLA-A*31:01 allele: influence on carbamazepine treatment. | 2017 |
4 |
| 28 |
28340402 | Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01. | 2017 Apr |
4 |
| 29 |
28476759 | HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions. | 2017 Jun 6 |
1 |
| 30 |
28570299 | HLA-A*31: 01 and HLA-B*15:02 association with Stevens-Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population. | 2017 Jul |
1 |
| 31 |
28884973 | A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions. | 2017 Dec |
3 |
| 32 |
28891449 | Role of Pharmacogenomics in Antiepileptic Drug Therapy: Current Status and Future Perspectives. | 2017 |
1 |
| 33 |
28921647 | Pharmacogenomics Implementation at the National Institutes of Health Clinical Center. | 2017 Oct |
1 |
| 34 |
29125944 | HLA-A*31:01 and carbamazepine-induced DRESS syndrom in a sample of North African population. | 2017 Dec |
3 |
| 35 |
26537309 | Carbamazepine-induced HLA-A*3101 associated hypersensitivity syndrome mimicking mycosis fungoides. | 2016 Nov |
1 |
| 36 |
28101480 | Spectrum of Cutaneous Adverse Reactions to Levetiracetam and Human Leukocyte Antigen Typing in North-Indian Patients. | 2016 Dec |
2 |
| 37 |
25338670 | Personalized medicine approaches in epilepsy. | 2015 Feb |
1 |
| 38 |
26046144 | Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy. | 2015 Apr |
2 |
| 39 |
26138622 | Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery. | 2015 Nov |
1 |
| 40 |
26490229 | Development of a simple genotyping method for the HLA-A*31:01-tagging SNP in Japanese. | 2015 |
3 |
| 41 |
26555631 | Do HLA-A markers predict skin-reactions from aromatic antiepileptic drugs in a Norwegian population? A case control study. | 2015 Dec |
1 |
| 42 |
24268988 | Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations. | 2014 Feb |
3 |
| 43 |
24322785 | HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. | 2014 Jun |
7 |
| 44 |
24388047 | Simple and rapid detection of HLA-A*31:01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method. | 2014 Apr |
2 |
| 45 |
24476427 | HLA restriction of carbamazepine-specific T-Cell clones from an HLA-A*31:01-positive hypersensitive patient. | 2014 Feb 17 |
4 |
| 46 |
24593191 | Rapid detection of HLA-A*31:01 allele in DNA and blood samples using loop-mediated isothermal amplification. | 2014 Jul |
1 |
| 47 |
24597466 | Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. | 2014 Apr |
3 |
| 48 |
24635066 | Presence of the HLA-A*3101 allele in a familial case of drug reaction with eosinophilia and systemic symptoms, secondary to carbamazepine. | 2014 Apr |
1 |
| 49 |
24882392 | Carbamazepine-induced cutaneous reactions: a simple assay to identify patients carrying the HLA-A*31:01 allele. | 2014 Oct |
4 |
| 50 |
25495410 | HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients. | 2014 |
1 |